5J·

Novo Nordisk - CICC starts coverage with Outperform 📈

Target price $73.50 | Currently $57.5 (upside ~28%)

$NOVO B (-1,07 %)
$NVO (-1,17 %)

11 Commentaires

DeepQuality@DeepQuality

Almost got in at the total bottom, now the yield is raining 👌

•

Aric@Swamp_German

@DeepQuality me to have bought some at 38€, buy in at 42.5€

••

sakamotoo@sakamotoo

@DeepQuality I think many, including myself, are definitely still in the doldrums here :D my average entry price is €51.50

••

HamsterFrodo@HamsterFrodo

@sakamotoo Mine is still at €58. But I got in at €84 and kept buying more, the last time at €40.30

•

Leon@Investingyoung

@DeepQuality don't want to make this one but we are still far from safely recovered, baba share still for dividend focus

••

Smudo@Smudeo

@Investingyoung if dividends remain, but since sales and profits are falling, I would not call this a dividend stock.
Advantage of eliminating or reducing dividends - more money in the store - rising share prices

••

DeepQuality@DeepQuality

@Investingyoung nothing is certain in life 😅 but we have clear recovery factors, the fundamental data looked good for a long time but the price continued to fall, then the bleeding stopped at ~€40 price more or less stabilized, now even with positive news we reach price momentum.

••

Daffy@Daffy

@DeepQuality I got in at €39, let's see if the recovery is sustainable.

••

Philipp@PS24

Same, unfortunately only with a small position

••

livkasmile@livkasmile

Maybe there will be an ozempic tax when you buy a chocolate in future 😀 every creeping calorie counts here... This business can't be beaten.

••

Pawfolio@Pawfolio

It is already the largest position in the portfolio 😆

••